Results 91 to 100 of about 8,384 (181)

Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review. [PDF]

Biomedicines
Ciarloni A, Salvio G, Bordoni M, Giacchetti G, Balercia G.   +4 more
europepmc   +1 more source

Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue. [PDF]

J Med Chem
Fischer Munch H, Just R, Mosolff Mathiesen J, Eriksson PO, Skodborg Villadsen J, Vestergaard B, Deryabina M, Demmer O, Skarbaliene J, Hamprecht DW, Rist W, Baader-Pagler T, Grube A, Heim-Riether A, Giehm L.   +14 more
europepmc   +1 more source

Pancreatic hypersecretion of amyloid-forming human amylin dysregulates the neuro-immune axis and B cell development in a model of type-2 diabetes. [PDF]

Neurobiol Dis
Winford ED, Shahidehpour R, Dressman D, Turchan-Cholewo J, Cotter KM, Leibold N, Ujas TA, Britsch DRS, Mercurio D, Colson MK, Verma N, Despa S, Bachstetter AD, Despa F, Stowe AM.   +14 more
europepmc   +1 more source

Toxicological profile of anti-diabetic drugs and emerging measures to reduce the toxic burden. [PDF]

Toxicol Rep
Dugbartey GJ, Alornyo KK, Dapaa-Addo CO, Kwashie EK, Harley Y, Asiedu BN.   +5 more
europepmc   +1 more source

Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. [PDF]

Mol Metab
Briere DA, Qu H, Lansu K, He MM, Moyers JS, Coskun T, Long A, Allen D, O'Farrell L, Bowen B, Pratt E, Tidemann-Miller B, Tham LS, Ibriga H, Alsina-Fernandez J, Mather KJ, Haupt A, Bhattachar SN.   +17 more
europepmc   +1 more source

Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]

Front Endocrinol (Lausanne)
Alhazmi A, le Roux CW.
europepmc   +1 more source

Human amylin is a potent antimicrobial peptide that exhibits antimicrobial synergism with the amyloid beta protein. [PDF]

Alzheimers Dement
Vijaya Kumar DK, Mitchell TA, Tailor BA, Moir AP, Navalpur Shanmugam NK, Eimer WA, Ghelichi J, Choi SH, Su C, Rodriguez AS, Kim E, Moir RD, Tanzi RE.   +12 more
europepmc   +1 more source

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials. [PDF]

Diabetes Obes Metab
Brændholt Olsen M, Griffin J, Hövelmann U, Macura S, Fredsted Hagen B, Hesse D, Heise T.   +6 more
europepmc   +1 more source

Light-Mediated Insulin and Amylin Secretion: Influence of Irradiation Parameters in Optogenetically Modified Mouse-Pancreatic β Cells. [PDF]

J Biophotonics
Maharwal N, Shrivastava R, Sahu K, Majumder SK.   +3 more
europepmc   +1 more source

Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. [PDF]

Physiol Behav
Kern KA, DiBrog AM, Demieri E, Przybysz JT, Clark SD, Mietlicki-Baase EG.   +5 more
europepmc   +1 more source